Paulsen L, Holst LM, Bech JN, et al. Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men[J]. Scand J Clin Lab Invest, 2009, 69(3): 323-329.
[2]
Li JJ, Fang CH. C-reactive potein is not only an inflammatory maker but also a direct cause of cardiovascular disease[J]. Med Hypotheses, 2004, 62(4): 499-506.
Ge CJ, Lu SZ, Chen YD, et al. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling and C-reactive protein in hypertensive patients with primary hypercholesterolemia[J]. Heart Vesse1s, 2008, 23(2): 91-95.
[5]
Asher J, Houston M. Statins and C-reactive protein levels[J]. Clin Hypertens (Greenwich), 2007, 9(8): 622-628.
[6]
Castro PF, Miranda R, Verdejo HE. Pleiotropic effects of atorvastatin in heart failure; role in oxidative stress, inflammation, endothelial function, and exercise capacity[J]. J Heart Lung Transplant, 2008, 27(4): 435-441.
[7]
Mondo CK, Yang WS, Su JZ, et al. Atorvastatin prevented and reversed dexamethasone-induced hypertension in the rat[J]. Clin Exp Hypertens, 2006, 28(5): 499-509.
[8]
Kanbay M,Yildirir A, Bozbas H, et al. Statin therapy helps to controlblood pressure levels in hypertensive dyslipidemic patients[J]. Ren Fail, 2005, 27(3): 297-303.
[9]
Liao Y, Zhao H,Ogai A, et al. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation[J]. Hypertens Res, 2008, 31(2): 335-344.
[10]
Paulsen L, Holm C, Bech JN, et al. Eiffects of statins on renal sodium and water handling:acute and short-term eiffects of atorvastatin on renal haemodynamics,tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans[J]. Nephrol Dial Transplant, 2008, 23(5): 1556-1561.
[11]
Rikitake Y, Liao JK. Rho CTPases, statins, and nitric Oxide[J].Circ Res, 2005, 97(12): 1232-1235.
[12]
Borghi C, Prandin MG, Costa FV, et al. Use of stains and blood pressure control in hypertensive patients with hypercholesterolemia[J].J Cardiovase Pharmacol, 2000, 35(4): 549-555.
[13]
Krzesinski JM. Firest evidence of greater cardiovascular protective effects of newer as compared to old antihypertensive drugs ireatments: the ASCOT-BPLA results[J].Rev Med Liege, 2005, 60(10): 820-826.
[14]
Ferrie KE, Muhlmann MH, Baguet JP, et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic Hypertension[J]. J Am Coll Cardiol, 2002, 39(6): 1020-1025.
[15]
Golobm BA, Dimsdle JE, White HL, et al. Reduction in blood pressure with stations,results from UCSD Statin Study,a randomized trial[J]. Arch Intern Med, 2008, 168(7): 721-727.
